Hatice AKKAYA, Gülsüm UYSAL

Relationship between first trimester vaginal bleeding and the risk of placental abruption

The aim of this study was to analyze influence of first trimester vaginal bleeding on the risk of placental abruption, as well as to assess the relation of first trimester bleeding and perinatal outcome in this patients with placental abruption. The second objective was to assess the connection of first trimester bleeding with low pregnancy-associated plasma protein-A and maternal serum alpha-fetoprotein with placental abruption. This is the first study that evaluated all relations these analytes in placental abruption with first trimester bleeding. Spontaneous, singleton pregnancies with live fetus ≥26 weeks of gestation with placental abruption were divided into two groups based on their prensence of first-trimester bleeding (Group 1) or without (Group 2). Maternal age, parity, smoking habits, body mass index, history of abortion and abruption, levels of pregnancy-associated plasma protein-A and Alpha-fetoprotein were also analyzed and compared. Main outcome measures were, mean gestational age, gender of baby, APGAR scores, birth length and weight and cesarean section rates. A total of 122 patients were included in the study.There were 44 patients accompanied with first trimester bleeding (group 1) and 78 patients without first trimester bleeding (group 2). The neonatal birthweight was significantly lower in first trimester bleeding group. The rate of smoking mother was significantly higher in first trimester bleeding group. Regarding serum maternal biomarkers, pregnancy-associated plasma protein-A≤0.5 and Alpha-fetoprotein ≥2 MOM was significantly higher in first trimester bleeding group.First trimester bleeding should alert clinicians for the signs of later possible complications in addition to low regnancy-associated plasma protein-A(≤0.5 MOM) and higher Alpha-fetoprotein (≥2 MOM) levels. Presence of vaginal bleeding in first trimester are related with poor maternal and fetal outcome at birth in patient with placental abruption.

PDF

___

Hossain R, Harris T, Lohsoonthorn V, et al. Risk of preterm delivery in relation to vaginal bleeding in early pregnancy. Eur J Obstet Gynecol Reprod Biol. 2007;135:158-63.

Weiss JL, Malone FD, Vidaver J, et al.; FASTER Consortium. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004;190:745-50.

Ananth CV, Oyelese Y, Prasad V, et al. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol. 2006;128:15-21.

Petriglia G, Palaia I, Musella A, et al. Threatened abortion and latepregnancy complications: a case-control study and review of literature. Minerva Ginecol. 2015;67:491-7.

Eriksen G, Wohlert M, Ersbak V, et al. Placental abruption. A case-control investigation. Br J Obstet Gynaecol. 1991;98:448-52.

Esmon CT. Does inflammation contribute to thrombotic events? Haemostasis. 2000;30:34-40.

Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol. 2001;185:1059-63.

Saraswat L, Bhattacharya S, Maheshwari A, et al. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG. 2010;117:245-57.

Huynh L, Kingdom J, Akhtar S. Low pregnancy-associated plasma protein A level in the first trimester. Can Fam Physician. 2014;60:899-903.

Gupta S, Goyal M, Verma D, et al. Adverse pregnancy outcome in patients with low pregnancy-associated plasma protein-A: The Indian Experience. J Obstet Gynaecol Res. 2015;41:1003-8.

Conover CA, Bale LK, Overgaard MT et al. Metalloproteinases pregnancy associated plasma protein A is a critical growth factor during fetal development. Development. 2004;131:1187–94.

Ananth CV, Wapner RJ, Ananth S, et al. First-Trimester and SecondTrimester Maternal Serum Biomarkers as Predictors of Placental Abruption. Obstet Gynecol. 2017;129:465-72.

Spong CY, Ghidini A, Walker CN, et al. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia. Am J Obstet Gynecol. 1997;177:1085–7.